A major US-affiliated brokerage maintained its Underweight rating on KOBAYASHI PHARMACEUTICAL and raised its target price to ¥4,100.
A report distributed at 16:33 on 2 November stated that a major US-affiliated brokerage maintained its Underweight rating on KOBAYASHI PHARMACEUTICAL CO.,LTD. <4967> and raised its target price from ¥3,950 to ¥4,100. Dexerials, Shiseido, Unicharm and Kao were also cited as related stocks.
The article stated that, as of the previous day (28 October), the rating consensus was 2.67 based on 6 analysts, representing a neutral level, while the target-price consensus was ¥5,428, also based on 6 analysts.